These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11033445)

  • 1. Expression of P2 receptors in bone and cultured bone cells.
    Hoebertz A; Townsend-Nicholson A; Glass R; Burnstock G; Arnett TR
    Bone; 2000 Oct; 27(4):503-10. PubMed ID: 11033445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells.
    Hoebertz A; Meghji S; Burnstock G; Arnett TR
    FASEB J; 2001 May; 15(7):1139-48. PubMed ID: 11344082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP P2 receptors and regulation of bone effector cells.
    Gallagher JA
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):125-7. PubMed ID: 15615109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.
    Buckley KA; Hipskind RA; Gartland A; Bowler WB; Gallagher JA
    Bone; 2002 Nov; 31(5):582-90. PubMed ID: 12477572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption.
    Bowler WB; Littlewood-Evans A; Bilbe G; Gallagher JA; Dixon CJ
    Bone; 1998 Mar; 22(3):195-200. PubMed ID: 9514211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of purinergic receptor polymorphisms in human bone.
    Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X(4) purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts.
    Naemsch LN; Weidema AF; Sims SM; Underhill TM; Dixon SJ
    J Cell Sci; 1999 Dec; 112 ( Pt 23)():4425-35. PubMed ID: 10564660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts.
    Naemsch LN; Dixon SJ; Sims SM
    J Biol Chem; 2001 Oct; 276(42):39107-14. PubMed ID: 11495918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
    Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
    Hoebertz A; Mahendran S; Burnstock G; Arnett TR
    J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
    Fumagalli M; Brambilla R; D'Ambrosi N; Volonté C; Matteoli M; Verderio C; Abbracchio MP
    Glia; 2003 Sep; 43(3):218-03. PubMed ID: 12898701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
    Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
    Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
    Solgaard M; Jørgensen NR
    Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing.
    Coutinho-Silva R; Parsons M; Robson T; Burnstock G
    Cell Tissue Res; 2001 Dec; 306(3):373-83. PubMed ID: 11735037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
    Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
    J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
    Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.